Skip to Main

Search

Results 571 to 580 of 1,032 for ""

UTSW researchers develop rapid COVID-19 test to identify variants in hours: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/june-rapid-covid-test.html

In just a few hours, UT Southwestern scientists can tell which variant has infected a COVID-19 patient – a critical task that can potentially influence treatment decisions but takes days or weeks at most medical centers.

Molecular imaging innovator Samuel Achilefu, Ph.D., to launch, lead Biomedical Engineering Department at UT Southwestern: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/achilefu-molecular-imaging-innovator.html

Samuel Achilefu, Ph.D., nationally recognized for expertise in molecular imaging and its application in treating human diseases, has been selected inaugural Chair to launch a new Department of Biomedical Engineering (BME) at UT Southwestern Medical Center.

UTSW study finds p53 gene plays second role in suppressing genes tied to cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-p53-gene-plays-second-role.html

A gene that’s well known for its role in turning on tumor-suppressing genes when cells become stressed also keeps potential tumor-driving genes turned off, UT Southwestern researchers report in a new study.

Telemedicine, continuous glucose monitoring mitigated effects of pandemic on children with diabetes : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/effects-of-pandemic-on-children-with-diabetes.html

The rapid adoption of telemedicine and increased use of continuous glucose monitoring helped to attenuate the impacts of the COVID-19 pandemic on children with Type 1 diabetes.

For older adults, hearing loss and falls go hand in hand : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-hearing-loss-and-falls.html

More than 1 in 3 Americans over age 65 will fall each year, according to the National Institute on Aging. In addition, approximately 1 in 3 individuals between 65 and 74 has hearing loss.

New guidelines laid out to standardize swallowing fluoroscopy : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-guidelines-swallowing-fluoroscopy.html

Swallowing fluoroscopy is the most common diagnostic test for patients with swallowing problems caused by conditions such as stroke, head and neck cancer, neurodegenerative disease, or prolonged intubation.

Financial assistance programs improve outcomes for indigent patients with inflammatory bowel disease: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-financial-assistance-programs.html

Patients with inflammatory bowel disease (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.

New drug combination offers hope for improved treatment of cervical cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-new-drug-combination.html

A new combination of drugs slowed the growth of cancer cells by an unexpected mechanism that may one day lead to improved treatment of cervical cancer, a UT Southwestern-led study published in Molecular Cancer Research suggests.

Potential genetic regulators of the heartbeat identified by UT Southwestern researchers : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-genetic-regulators-of-the-heartbeat.html

UT Southwestern Medical Center researchers have mapped gene control elements in specialized cardiac cells responsible for coordinating heartbeats.

Drug shows promise in overcoming endocrine therapy resistance in breast cancer : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-endocrine-therapy-resist.html

For patients with estrogen receptor (ER)-positive breast cancer, development of the so-called Y537S mutation signals that their disease has taken an aggressive course and may become resistant to endocrine therapy.